Research highlights extended duration of ADHD medication for Finnish children

Research highlights extended duration of ADHD medication for Finnish children

A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance Institution Kela reveals that the average duration of ADHD medication for children and adolescents is more than three years.

Research raises concerns about the safety of long-term ADHD medication treatment in children

A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance Institution Kela reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ADHD medicines in children are available for only one year of follow-up.

Early ADHD Treatment May Mean Years on Medication

A large Finnish registry study reveals that many children, especially boys who begin ADHD medication between ages 6 and 8, remain on treatment for more than seven years. While the average duration of ADHD medication was over three years, a quarter of treated children remained on it for over seven, and some for nearly a decade.